The study assesses Continuous Glucose monitors accuracy in adults with Diabetic Ketoacidosis (DKA) to improve treatment and ...

"In Type 1 and Type 2 diabetes, RT-CGM lowered HbA1c, improved time spent within the target glucose range (70–180 mg/dL), and reduced episodes of hypoglycemia in T1D and hypergl ...

Individuals transitioning from multiple daily injections to the Omnipod 5 system experienced an average HbA1c reduction of ...

Insulet Corporation’s RADIANT study shows glycaemic improvements with Omnipod 5 automated insulin delivery system: Action, Massachusetts Friday, March 21, 2025, 18:00 Hrs [IST] ...

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

Care announced publication by The New England Journal of Medicine of results from the company’s pivotal trial of Control-IQ+ ...

Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

Continuous Glucose Monitors Revolutionize Diabetic Ketoacidosis ManagementDiabetic ketoacidosis is a common severe ...

A randomized study from Insulet of adults and children with Type 1 diabetes found that moving from multiple daily injections ...

Health Canada has issued a warning to those who use continuous glucose monitors (CGMs) to monitor their blood sugar after ...

Understanding your blood sugar levels after eating is a key part of maintaining overall health. Whether you’re managing ...

Let’s dig into the relative performance of Insulet (NASDAQ:PODD) and its peers as we unravel the now-completed Q4 patient ...